As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Glendy
Insight Reader
2 hours ago
I read this and now I trust nothing.
👍 14
Reply
2
Lorenz
Regular Reader
5 hours ago
Expert US stock short interest and short squeeze potential analysis for identifying high-risk high-reward opportunities. Our short interest data helps you understand bearish sentiment and potential catalysts for short covering rallies.
👍 222
Reply
3
Lilley
Returning User
1 day ago
Expert US stock analyst coverage consensus and rating distribution analysis to understand market sentiment. We aggregate analyst opinions to provide a consensus view of Wall Street expectations for any stock.
👍 299
Reply
4
Jvian
Active Contributor
1 day ago
Market participants are navigating current conditions carefully, balancing risk and reward considerations.
👍 40
Reply
5
Nakee
Expert Member
2 days ago
This feels like something is about to break.
👍 294
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.